Overview
- 167 inspections across 151 sites are on record.
- 343 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-02-27.
At a glance
Inspections
167
Sites
151
Observations
343
Career since
Jan 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Reliance Life Sciences Private Limited | 27 Feb 2026 | Human Drugs | On file |
| Alembic Pharmaceuticals Limited | 18 Feb 2026 | Human Drugs | On file |
| Gland Pharma Limited | 25 Feb 2025 | Human Drugs | On file |
| Eugia Steriles Private Limited | 18 Feb 2025 | Human Drugs | View 483 → |
| Cardinal Health 414, LLC | 20 Aug 2024 | Human Drugs |
Sites inspected
Reliance Life Sciences Private LimitedNavi Mumbai, India1 insp.
Alembic Pharmaceuticals LimitedVadodara, India1 insp.
Gland Pharma LimitedParawada, Anakapalli, India1 insp.
Eugia Steriles Private LimitedAnakapalli, India1 insp.
Cardinal Health 414, LLCSacramento, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jennifer S King20 shared
Deborah K Richardson13 shared
Eileen A Liu9 shared
Michelle L Tripp9 shared
David Eng4 shared
Anh Lac4 shared
Zachary L Stamm3 shared
Rumany C Penn3 shared
Tamil Arasu3 shared
James C Lee3 shared
Full investigator report
Get the verbatim findings behind Ashar P Parikh's 343 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site